Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
- PMID: 22487856
- PMCID: PMC3560290
- DOI: 10.1097/NEN.0b013e31825018f7
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
Abstract
Clinicopathologic correlation studies are critically important for the field of Alzheimer disease (AD) research. Studies on human subjects with autopsy confirmation entail numerous potential biases that affect both their general applicability and the validity of the correlations. Many sources of data variability can weaken the apparent correlation between cognitive status and AD neuropathologic changes. Indeed, most persons in advanced old age have significant non-AD brain lesions that may alter cognition independently of AD. Worldwide research efforts have evaluated thousands of human subjects to assess the causes of cognitive impairment in the elderly, and these studies have been interpreted in different ways. We review the literature focusing on the correlation of AD neuropathologic changes (i.e. β-amyloid plaques and neurofibrillary tangles) with cognitive impairment. We discuss the various patterns of brain changes that have been observed in elderly individuals to provide a perspective for understanding AD clinicopathologic correlation and conclude that evidence from many independent research centers strongly supports the existence of a specific disease, as defined by the presence of Aβ plaques and neurofibrillary tangles. Although Aβ plaques may play a key role in AD pathogenesis, the severity of cognitive impairment correlates best with the burden of neocortical neurofibrillary tangles.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3560290/bin/nihms391138f1.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3560290/bin/nihms391138f2.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3560290/bin/nihms391138f3.gif)
![FIGURE 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3560290/bin/nihms391138f4.gif)
![FIGURE 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3560290/bin/nihms391138f5.gif)
Similar articles
-
Neuropathological changes in aging brain.Adv Exp Med Biol. 2015;821:11-7. doi: 10.1007/978-3-319-08939-3_6. Adv Exp Med Biol. 2015. PMID: 25416106 Review.
-
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.J Neuropathol Exp Neurol. 2009 Jan;68(1):1-14. doi: 10.1097/NEN.0b013e3181919a48. J Neuropathol Exp Neurol. 2009. PMID: 19104448 Free PMC article. Review.
-
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.J Neuropathol Exp Neurol. 2007 Dec;66(12):1136-46. doi: 10.1097/nen.0b013e31815c5efb. J Neuropathol Exp Neurol. 2007. PMID: 18090922 Free PMC article.
-
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.Arch Neurol. 1998 Mar;55(3):326-35. doi: 10.1001/archneur.55.3.326. Arch Neurol. 1998. PMID: 9520006
-
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.Arch Gen Psychiatry. 1998 Mar;55(3):205-11. doi: 10.1001/archpsyc.55.3.205. Arch Gen Psychiatry. 1998. PMID: 9510214
Cited by
-
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons.Front Aging Neurosci. 2024 May 14;16:1400544. doi: 10.3389/fnagi.2024.1400544. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38808033 Free PMC article. Review.
-
Trait-anxiety and glial-related neuroinflammation of the amygdala and its associated regions in Alzheimer's disease: A significant correlation.Brain Behav Immun Health. 2024 May 14;38:100795. doi: 10.1016/j.bbih.2024.100795. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38799793 Free PMC article.
-
The influence of APOEε4 on the pTau interactome in sporadic Alzheimer's disease.Acta Neuropathol. 2024 May 21;147(1):91. doi: 10.1007/s00401-024-02744-8. Acta Neuropathol. 2024. PMID: 38772917 Free PMC article.
-
Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change.Brain Commun. 2024 Apr 17;6(3):fcae141. doi: 10.1093/braincomms/fcae141. eCollection 2024. Brain Commun. 2024. PMID: 38712319 Free PMC article.
-
Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model.Brain Behav Immun Health. 2024 Apr 24;38:100780. doi: 10.1016/j.bbih.2024.100780. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38706571 Free PMC article.
References
-
- Alzheimer A. Über eigenartige Krankheitsfälle des späteren Lebensalters. Z Ges Neurol. 1911;4:356–85.
-
- Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol Aging. 1997;18:S1–2. - PubMed
-
- Beach TG. The history of Alzheimer’s disease: Three debates. J Hist Med Allied Sci. 1987;42:327–49. - PubMed
-
- Boller F, Bick K, Duyckaerts C. They have shaped Alzheimer disease: The protagonists, well known and less well known. Cortex. 2007;43:565–69. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 AG013854/AG/NIA NIH HHS/United States
- P30 AG010124/AG/NIA NIH HHS/United States
- AG10124/AG/NIA NIH HHS/United States
- R01 AG022102/AG/NIA NIH HHS/United States
- U19 AG010483/AG/NIA NIH HHS/United States
- P50 AG005136/AG/NIA NIH HHS/United States
- R01 AG006647/AG/NIA NIH HHS/United States
- P01 AG002219/AG/NIA NIH HHS/United States
- U01 AG006781/AG/NIA NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- AG016976/AG/NIA NIH HHS/United States
- AG08051/AG/NIA NIH HHS/United States
- RF1 AG015819/AG/NIA NIH HHS/United States
- R01 NS073502/NS/NINDS NIH HHS/United States
- R01 AG020245/AG/NIA NIH HHS/United States
- AG05138/AG/NIA NIH HHS/United States
- R37 AG006647/AG/NIA NIH HHS/United States
- AG028383/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- AG02219/AG/NIA NIH HHS/United States
- AG15819/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- AG008017/AG/NIA NIH HHS/United States
- AG05681/AG/NIA NIH HHS/United States
- AG05136/AG/NIA NIH HHS/United States
- AG10161/AG/NIA NIH HHS/United States
- AG13854/AG/NIA NIH HHS/United States
- AG035071/AG/NIA NIH HHS/United States
- AG06647/AG/NIA NIH HHS/United States
- R37 AG022102/AG/NIA NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- R01 AG035071/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical